Multidrug resistant Acinetobacter baumannii;Multirezistentní Acinetobacter baumannii

Klinicka Mikrobiologie a Infekcni Lekarstvi

Volumn 14, Issue 5, 2008, Pages 162-167

  Nemec, Alexander ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

Acinetobacter baumannii; Czech Republic; Epidemic clones; Multidrug resistance

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; GENTAMICIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CZECH REPUBLIC; EPIDEMIC; EUROPEAN UNION; HOSPITAL INFECTION; INTENSIVE CARE UNIT; MICROBIAL POPULATION DYNAMICS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; POPULATION STRUCTURE; REVIEW;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; CROSS INFECTION; CZECH REPUBLIC; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS;

EID: 58649117993     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. McGowan JE Jr. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Med. 2006 Jun;119(6 Suppl 1):S29-36.
2. Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother 2008;62 Suppl 1:i1-9.
3. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008; 197(8):1079-1081.
4. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007;5(12):939-951.
5. Jawad A, Seifert H, Snelling AM, et al. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 1998;36(7):1938-1941.
6. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21(3):538-582.
7. Nemec A, Musílek M, Maixnerová M, et al. Acinetobacter beijerinckii sp. nov. and Acinetobacter gyllenbergii sp. nov., haemolytic organisms isolated from humans. Int J Syst Evol Microbiol, in press.
8. Nemec A, Křízová L, Maixnerová M, et al. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother. 2008; 62(3):484-489.
9. Nemec A, Janda J, Melter O, Dijkshoorn L. Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii isolates in the Czech republic. J Med Microbiol 1999;48(3):287-296.
10. Bernards AT, van der Toorn J, van Boven CP, Dijkshoorn L. Evaluation of the ability of a commercial system to identify Acinetobacter genomic species. Eur J Clin Microbiol Infect Dis. 1996;15(4):303-308.
11. Gerner-Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol 1991;29(2):277-282.
12. Dijkshoorn L, Aucken H, Gerner-Smidt P et al. Comparison of outbreak and non-outbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol 1996;34(6):1519-1525.
13. Nemec A, Dijkshoorn L, van der Reijden TJK. Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J Med Microbiol 2004; 53(Pt 2):147-153.
14. Da Silva G, Dijkshoorn L, van der Reijden T, et al. Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II. Clin Microbiol Infect 2007;13(2):190-195.
15. Turton JF, Gabriel SN, Valderrey C, et al. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 2007;13(8):807-815.
16. Landman D, Butnariu M, Bratu S, Quale J. Genetic relatedness of multidrug-resistant Acinetobacter baumannii endemic to New York City. Epidemiol Infect 2008 May 27:1-7. [Epub ahead of print]
17. Iacono M, Villa L, Fortini D, et al. Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob Agents Chemother 2008;52(7):2616-2625.
18. Wroblewska MM, Towner KJ, Marchel H, Luczak M. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland. Clin Microbiol Infect 2007;13(5):490-496.
19. van Dessel H, Dijkshoorn L, van der Reijden T et al. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol 2004;155(2):105-112.
20. Bartual SG, Seifert H, Hippler C, et al. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005;43(9):4382-4390.
21. Diancourt L, Passet V, Nemec A, et al. Precise identification and phylogenetic, relationships of major multi-resistant clones of Acinetobacter baumannii by multilocus sequence typing (abstract O147]. In: 17th ECCMID/25th ICC, Munich, Germany, 31 March-3 April 2007. Clin Microbiol Infect 2007; 13(suppl 1): S30.
22. Heritier C, Poirel L, Nordmann P. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect 2006;12(2):123-130.
23. Turton JF, Ward ME, Woodford N, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006;258(1):72-77.
24. Livermore DM, Woodford N. The -lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 2006;14(9):413-420.
25. Magnet S, Courvalin P, Lambert, T. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother 2001;45(12):3375-3380.
26. Marchand I, Damier-Piolle L, Courvalin P, Lambert, T. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother 2004;48(9):3298-3304.
27. Nemec A, Maixnerová M, van der Reijden TJ, et al. Relationship between the AdeABC efflux system gene content, netilmicin susceptibility and multidrug resistance in a genotypically diverse collection of Acinetobacter baumannii strains. J Antimicrob Chemother 2007;60(3):483-489.
28. Nemec A, Dolzani L, Brisse S, et al. Diversity of aminoglycoside resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol. 2004;53(Pt 12):1233-1240.
29. Nemec A, van der Reijden TJK, Dijkshoorn L. Multirezistentní klony Acinetobacter baumannii v České republice. Klin Mikrobiol Inf Lék 2003;9(3):130-137.
30. Nemec A. Využití diskového difúzního testu v epidemiologické typizaci multi-rezistentních kmenů Acinetobacter baumannii. Klin Mikrobiol Inf Lék 1999; 5(9-10):287-297.
31. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
32. Ruzin A, Keeney D, Bradford PA. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex. J Antimicrob Chemother 2007;59(5):1001-1004.
33. Peleg AY, Adams J, Paterson DL. Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii. Antimicrob Agents Chemother 2007;51(6):2065-2069.
34. Vila J, Pachón J. Therapeutic options for Acinetobacter baumannii infections. Expert Opin Pharmacother 2008;9(4):587-599.